A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — long-lived cells that help repair and replace damaged tissue in the lungs — ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune system better recognize and respond to small cell lung cancer. The study aims to ...

Dr. Zhonglin Hao says small cell lung cancer usually occurs in smokers and often recurs after treatments that are currently available. (University of Kentucky photo) If you smoke and want to quit, ...

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC). However, its cost raises questions about ...

Small cell lung cancer, or SCLC, is aggressive, lethal and particularly cruel because chemotherapy initially works so well. But within just a few months, SCLC becomes resistant to drugs and dashes ...

After being described in 2018, researchers knew they had something interesting with T3p, a single small RNA found in breast ...

Then you have the fact that clinical trials often underrepresent minorities. This can lead to skewed AI models, with 80 ...